Skip to main content
Caplight Logo









Vascurie AB

Vascurie AB

Private
UppsalaHealthcare & Life Scienceshttps://vascurie.com/

Last Round

Seed

Feb 9, 2026

Total Funding Raised

$534,000

Company Overview

Vascurie AB is a biopharmaceutical company that develops novel antibody-based therapies for the treatment of aggressive central nervous system tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalmonoclonal antibodyneuro-oncologyglioblastomadrug discoverybrain cancer therapypreclinical developmenttumor microenvironmentbiotechCNS tumorsantibody therapeuticsCD93targeted cancer therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vascurie AB Comparables

Compare Vascurie AB with similar companies based on industry and business-model similarity.

Vascurie AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DynamiCure Biotechnology
82%
PharmAbcine Inc.
70%
MabTics Co., Ltd.
67%

Vascurie AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 9, 2026

Vascurie AB Investors

Notable investors and investment history

Vascurie AB Filings

Explore SEC and related filing metadata, where available.

Vascurie AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vascurie AB's valuation, stock price, and market status.

Is Vascurie AB a public or private company?

Vascurie AB is a private company.

What is the current stock price of Vascurie AB?

Vascurie AB is a private company with no public stock price. No recent secondary market data is available.

How much is Vascurie AB worth (valuation)?

Valuation information for Vascurie AB is not publicly available.

Can I buy Vascurie AB stock?

Vascurie AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vascurie AB's last funding round?

Vascurie AB's most recent funding round was Seed on February 9, 2026.

Who are the main investors in Vascurie AB?

Key investors in Vascurie AB include Almi Invest AB.

Will Vascurie AB IPO soon?

No public IPO plans have been announced for Vascurie AB.

How can I track Vascurie AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vascurie AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUppsala
Year Founded2025
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?